The stock of Blue Water Vaccines Inc. (NASDAQ:BWV) last traded at $1.37, up 9.60% from the previous session.
Data from the available sources indicates that Blue Water Vaccines Inc. (NASDAQ:BWV) is covered by 2 analysts. The consensus rating among analysts is ‘Buy’. As we calculate the median target price by taking the range between a high of $7.00 and a low of $4.00, we find $5.50. Given the previous closing price of $1.25, this indicates a potential upside of 340.0 percent. BWV stock price is now 16.22% away from the 50-day moving average and -60.77% away from the 200-day moving average. The market capitalization of the company currently stands at $19.30M.
Will You Miss Out On This Growth Stock Boom?
A new megatrend in the fintech market is well underway. Mobile payments are projected to boom into a massive $12 trillion market by 2028. According to Motley Fool this growth stock could "deliver huge returns." Not only in the immediate future but also over the next decade. Especially since the man behind this company is a serial entrepreneur who has been wildly successful over the years.
And this is just one of our
5 Best Growth Stocks To Own For 2023.
Sponsored
In total, 0 analysts have assigned it a hold rating, and 2 have given it a buy rating. Brokers who have rated the stock have averaged $5.50 as their price target over the next twelve months.
.
In other news, Hernandez Joseph, CEO sold 30,269 shares of the company’s stock on Aug 22. The stock was sold for $124,206 at an average price of $4.10. Upon completion of the transaction, the CEO now directly owns 2,650,351 shares in the company, valued at $3.63 million. An SEC document containing details of the transaction can be found on the SEC’s website. On Aug 19, Director Shaw Allan sold 29,636 shares of the business’s stock. A total of $116,766 was realized by selling the stock at an average price of $3.94. Insiders disposed of 1,834,119 shares of company stock worth roughly $2.51 million over the past 1 year. A total of 17.30% of the company’s stock is owned by insiders.
There have been several recent changes in the stakes of large investors in BWV stock. A new stake in Blue Water Vaccines Inc. shares was purchased by ARMISTICE CAPITAL, LLC during the first quarter worth $1,176,000. CETERA ADVISOR NETWORKS LLC invested $182,000 in shares of BWV during the first quarter. In the first quarter, VANGUARD GROUP INC acquired a new stake in Blue Water Vaccines Inc. valued at approximately $62,000. MILLENNIUM MANAGEMENT LLC acquired a new stake in BWV for approximately $54,000. TWO SIGMA INVESTMENTS, LP purchased a new stake in BWV valued at around $47,000 in the second quarter. In total, there are 13 active investors with 20.50% ownership of the company’s stock.
With an opening price of $1.2500 on Friday morning, Blue Water Vaccines Inc. (NASDAQ: BWV) set off the trading day. During the past 12 months, Blue Water Vaccines Inc. has had a low of $0.91 and a high of $90.90. As of last week, the company has a debt-to-equity ratio of 0.00, a current ratio of 6.80, and a quick ratio of 6.80. The fifty day moving average price for BWV is $1.1836 and a two-hundred day moving average price translates $3.1843 for the stock.
The latest earnings results from Blue Water Vaccines Inc. (NASDAQ: BWV) was released for Jun, 2022.
Blue Water Vaccines Inc.(BWV) Company Profile
Blue Water Vaccines, Inc., a biotechnology company, engages in the research and development of vaccines to prevent infectious diseases worldwide. The company’s lead vaccine programs that are under preclinical development include BWV-101, an influenza vaccine; and BWV-102, a H1 pre-pandemic vaccine. It also develops other products that are under preclinical development comprising BWV-201, a streptococcus pneumoniae induced acute otitis media vaccine program; BWV-301, a norovirus-rotavirus vaccine program; and BWV-302, a norovirus-malaria vaccine program. The company was incorporated in 2018 and is based in Cincinnati, Ohio.
